Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) have been assigned an average rating of “Hold” from the nine research firms that are covering the stock, MarketBeat.com reports. Two investment analysts have rated the stock with a sell rating, two have assigned a hold rating, four have given a buy rating and one has issued a strong buy rating on the company. The average 1 year price objective among brokerages that have issued ratings on the stock in the last year is $30.50.

PAHC has been the topic of several research reports. Zacks Investment Research upgraded shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price objective on the stock in a report on Thursday, May 11th. BidaskClub raised shares of Phibro Animal Health Corporation from a “buy” rating to a “strong-buy” rating in a research note on Thursday, June 22nd. Piper Jaffray Companies set a $35.00 target price on shares of Phibro Animal Health Corporation and gave the company a “buy” rating in a research note on Friday, July 21st. Finally, Credit Suisse Group cut shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and upped their target price for the company from $29.00 to $36.00 in a research note on Friday, June 2nd.

Shares of Phibro Animal Health Corporation (NASDAQ:PAHC) traded down 0.25% during mid-day trading on Friday, reaching $39.35. The company had a trading volume of 29,618 shares. The company’s 50-day moving average is $37.65 and its 200 day moving average is $31.82. Phibro Animal Health Corporation has a 52-week low of $19.02 and a 52-week high of $39.95. The stock has a market capitalization of $1.56 billion, a P/E ratio of 24.44 and a beta of 1.35.

Phibro Animal Health Corporation (NASDAQ:PAHC) last announced its earnings results on Monday, May 8th. The company reported $0.37 EPS for the quarter, hitting the consensus estimate of $0.37. The firm had revenue of $190 million for the quarter, compared to the consensus estimate of $185.90 million. Phibro Animal Health Corporation had a net margin of 8.49% and a return on equity of 54.68%. The business’s quarterly revenue was up 3.5% on a year-over-year basis. During the same quarter last year, the firm posted $0.38 EPS. Analysts anticipate that Phibro Animal Health Corporation will post $1.45 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 27th. Stockholders of record on Wednesday, September 6th will be given a dividend of $0.10 per share. The ex-dividend date of this dividend is Friday, September 1st. This represents a $0.40 dividend on an annualized basis and a dividend yield of 1.01%. Phibro Animal Health Corporation’s payout ratio is 24.69%.

In other news, insider Jack Bendheim sold 48,000 shares of the company’s stock in a transaction that occurred on Thursday, May 25th. The shares were sold at an average price of $34.67, for a total transaction of $1,664,160.00. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Gerald K. Carlson sold 63,338 shares of the company’s stock in a transaction that occurred on Thursday, May 11th. The stock was sold at an average price of $33.31, for a total transaction of $2,109,788.78. Following the transaction, the director now owns 50 shares in the company, valued at $1,665.50. The disclosure for this sale can be found here. Insiders have sold 415,338 shares of company stock worth $14,708,989 over the last quarter. 48.09% of the stock is owned by company insiders.

A number of institutional investors have recently made changes to their positions in PAHC. Alps Advisors Inc. raised its position in shares of Phibro Animal Health Corporation by 0.3% in the second quarter. Alps Advisors Inc. now owns 17,541 shares of the company’s stock valued at $650,000 after buying an additional 46 shares in the last quarter. Louisiana State Employees Retirement System increased its stake in shares of Phibro Animal Health Corporation by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 7,500 shares of the company’s stock valued at $211,000 after buying an additional 100 shares during the last quarter. Arizona State Retirement System increased its stake in shares of Phibro Animal Health Corporation by 1.0% in the second quarter. Arizona State Retirement System now owns 9,800 shares of the company’s stock valued at $363,000 after buying an additional 100 shares during the last quarter. Municipal Employees Retirement System of Michigan increased its stake in shares of Phibro Animal Health Corporation by 3.6% in the second quarter. Municipal Employees Retirement System of Michigan now owns 4,370 shares of the company’s stock valued at $162,000 after buying an additional 150 shares during the last quarter. Finally, American Century Companies Inc. increased its stake in shares of Phibro Animal Health Corporation by 1.1% in the second quarter. American Century Companies Inc. now owns 18,905 shares of the company’s stock valued at $700,000 after buying an additional 205 shares during the last quarter. Institutional investors and hedge funds own 47.41% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This article was posted by Daily Political and is the property of of Daily Political. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.dailypolitical.com/2017/08/09/phibro-animal-health-corporation-pahc-given-average-rating-of-hold-by-brokerages.html.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Analyst Recommendations for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.